Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now

Frankfurt - Delayed Quote EUR

Orsero S.p.A. (WRG.F)

Compare

12.30

+0.02

+(0.16%)

As of 9:31:29 AM GMT+1. Market Open.

Oil slips to lowest level in 6 months amid trade war fears

Oil futures sank to six-month lows amid trade war worries and the prospects of more oil coming into the market.

Yahoo Finance 40 minutes ago

BZ=F

CL=F
Trump threatens to kill CHIPS Act, bringing funding into question

Trump's plan to kill the CHIPS Act would impact funding meant to bring semiconductor manufacturing back to the US.

Yahoo Finance 2 hours ago

TXN

GFS

TSM
Novo Nordisk offering weight-loss drug Wegovy at huge discount

Novo Nordisk (NVO) is now offering its GLP-1 weight-loss drug Wegovy at half its price, amounting to $499 per month. Catalysts co-hosts Seana Smith and Madison Mills report on the latest news surrounding the pharmaceutical giant's position in the obesity drug space. To watch more expert insights and analysis on the latest market action, check out more Catalysts here. This post was written by Luke Carberry Mogan.

Yahoo Finance Video 2 hours ago

NONOF

NVO

LLY
CrowdStrike stock slips after missing guidance expectations

CrowdStrike (CRWD) shares slip lower in Wednesday's pre-market trading, coming off of the cybersecurity firm's fourth quarter earnings results that beat expectations, while falling short of forecasts for its current first quarter and the full year. Seana Smith and Madison Mills dive into CrowdStrike's earnings figures — which were reported after the market close on Tuesday — and the analyst commentary around the stock. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. This post was written by Luke Carberry Mogan.

Yahoo Finance Video 3 hours ago

CRWD
JetBlue, Frontier Airlines downgraded to Hold by Deutsche Bank

Deutsche Bank (DB) downgraded JetBlue Airways (JBLU) and Frontier Airlines (ULCC) to Hold from Buy, citing an economic slowdown that will impact air travel demand. Market Domination anchors Julie Hyman and Josh Lipton discuss Deutsche Bank analyst Michael Linenberg's view that discount airlines like JetBlue and Frontier will suffer more than full-price carriers. Analysts have largely moved to Hold ratings for JetBlue, with no remaining Buy recommendations. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Josh Lynch

Yahoo Finance Video 20 hours ago

JBLU

DB

ULCC
CrowdStrike misses Q1, full-year revenue guidance. Stock falls.

Cybersecurity firm CrowdStrike (CRWD) tops earnings and revenue estimates for its fourth quarter, posting adjusted EPS of $1.03 (vs. expectations of $0.86) and revenue of $1.06 billion (slightly beating estimates for $1.03 billion). The stock appears to be initially reacting negatively in Tuesday's after-hours trading on CrowdStrike's first quarter and full-year revenue guidance, both data points missing Wall Street consensus. Julie Hyman and Josh Lipton break down the latest earnings print out from CrowdStrike this afternoon. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here. This post was written by Luke Carberry Mogan.

Yahoo Finance Video 21 hours ago

CRWD
Why Moderna (MRNA) Stock Is Rallying Today

Moderna (MRNA) stock is climbing 8% after the drug maker won a key court case and its CEO bought shares on the open market. MRNA’s Court Victory A German court ruled that BioNTech (BNTX) and Pfizer (PFE) have to pay Moderna damages because they infringed on Moderna’s mRNA patents. The court ordered BNTX and PFE […]

Insider Monkey 16 minutes ago

MRNA

PFE

BNTX
Moderna Scores Legal Victory Over Pfizer, BioNTech in Patent Dispute

Moderna's Patent Power Play Forces Pfizer, BioNTech to Pay Up

GuruFocus.com 17 minutes ago

PFE

MRNA

BNTX
How To Use High Volatility For A Short Strangle On Exxon Mobil Stock

Collecting premium when implied volatility is high makes sense but watch out for the higher risks in this advanced trade.

Investor's Business Daily 18 minutes ago

XOM
Jazz Pharmaceuticals bids for Chimerix in $935m deal

The acquisition will give Jazz access to Chimerix’s lead investigational candidate dordaviprone.

Pharmaceutical Technology 18 minutes ago

CMRX

JAZZ

GLDAF
Why Abercrombie and Fitch (ANF) Shares Are Plunging Today

Shares of young adult apparel retailer Abercrombie & Fitch (NYSE:ANF) fell 15.9% in the morning session after the company reported weak fourth quarter earnings: its EPS in the quarter missed and sales and EPS guidance for the next quarter were below expectations. The company expects 4-6% revenue growth in the first quarter and 3-5% for the full year, with 2025 operating margins projected to remain flat or decline slightly relative to the previous year.

StockStory 19 minutes ago

ANF
GM, Novo Nordisk, Moderna, Marvell, CrowdStrike: Stocks to watch today

U.S. stocks edged higher Wednesday afternoon, rebounding modestly from a sharp sell-off earlier in the week as Commerce Secretary Howard Lutnick suggested potential tariff relief for Canada and Mexico, hinting that the U.S. could find a compromise “in the middle.”

Quartz 22 minutes ago

NVO

CRWD

MRVL
Novo Nordisk Shares Climb as Wegovy Price Slashed Over 50%

Novo Nordisk Surges After Halving Wegovy Price, Rival Sinks

GuruFocus.com 22 minutes ago

NVO
CrowdStrike Holdings (NasdaqGS:CRWD) Reports US$4 Billion Fiscal Year Revenue Despite US$19 Million Net Loss

CrowdStrike Holdings (NasdaqGS:CRWD) released its earnings results for the fourth quarter, revealing substantial revenue growth to $1.06 billion, representing a 25% increase. However, the company reported a net loss of $92 million. Despite this, the company's guidance for fiscal 2026 forecasts strong revenue expectations. Over the past quarter, CrowdStrike's stock price gained 7.14%, which may reflect investor optimism about future revenue prospects, notwithstanding the recent net losses...

Simply Wall St. 24 minutes ago

CRWD
Why CrowdStrike (CRWD) Shares Are Getting Obliterated Today

Shares of cybersecurity company CrowdStrike (NASDAQ:CRWD) fell 10.8% in the morning session after the company reported mixed fourth quarter (fiscal 2025) results: Its full-year revenue guidance was just in line, while full-year operating profit guidance missed Wall Street's estimates.

StockStory 24 minutes ago

CRWD
Abercrombie & Fitch Stock Plunges as Outlook Underwhelms

Abercrombie & Fitch shares sank Wednesday after the apparel retailer's current-quarter profit and full-year sales forecasts disappointed investors.

Investopedia 28 minutes ago

ANF
CrowdStrike Collapses 9%--Is This the Beginning of the End or a Massive Buying Opportunity?

Wall Street just punished CrowdStrike after weak guidance--here's what's really going on and what investors should watch next.

GuruFocus.com 38 minutes ago

CRWD
Why CrowdStrike Stock Is Plummeting Today

CrowdStrike (NASDAQ: CRWD) stock is getting hit with a wave of sell-offs following the company's recent fourth-quarter report. CrowdStrike published its Q4 results after the market closed yesterday, actually reporting sales and earnings that beat Wall Street's expectations. CrowdStrike reported non-GAAP (adjusted) earnings per share of $1.03 on sales of $1.06 billion in the fourth quarter, topping the average analyst estimate's call for per-share earnings of $0.86 on sales of $1.04 billion.

Motley Fool 40 minutes ago

CRWD
Abercrombie & Fitch (NYSE:ANF) Reports Strong Q4 With Sales Up To US$1.6B And Net Income Rising To US$187M

Abercrombie & Fitch (NYSE:ANF) reported robust fourth quarter and full-year financial performance with notable increases in sales and net income, alongside a strong rise in earnings per share. Despite these positive results, the company's stock price declined by 5% over the past week. This decline occurred amid a broader market environment marked by investor caution surrounding tariffs and economic data releases, contributing to a 3% drop in market indexes. The mixed market signals, including...

Simply Wall St. 44 minutes ago

ANF
CrowdStrike Stock Is Down After a Disappointing Forecast, But Analysts Are Still Bullish

CrowdStrike shares tumbled Wednesday after the cybersecurity company’s full-year outlook disappointed, but several analysts said they still see upside for the stock.

Investopedia 49 minutes ago

CRWD

Performance Overview

Return	WRG.F	FTSE MIB Index
YTD	-1.13%	+12.68%
1-Year	-12.55%	+16.21%
3-Year	+14.15%	+71.46%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Orsero S.p.A. (WRG.F)

Related News

Oil slips to lowest level in 6 months amid trade war fears

Trump threatens to kill CHIPS Act, bringing funding into question

Novo Nordisk offering weight-loss drug Wegovy at huge discount

CrowdStrike stock slips after missing guidance expectations

JetBlue, Frontier Airlines downgraded to Hold by Deutsche Bank

CrowdStrike misses Q1, full-year revenue guidance. Stock falls.

Why Moderna (MRNA) Stock Is Rallying Today

Moderna Scores Legal Victory Over Pfizer, BioNTech in Patent Dispute

How To Use High Volatility For A Short Strangle On Exxon Mobil Stock

Jazz Pharmaceuticals bids for Chimerix in $935m deal

Why Abercrombie and Fitch (ANF) Shares Are Plunging Today

GM, Novo Nordisk, Moderna, Marvell, CrowdStrike: Stocks to watch today

Novo Nordisk Shares Climb as Wegovy Price Slashed Over 50%

CrowdStrike Holdings (NasdaqGS:CRWD) Reports US$4 Billion Fiscal Year Revenue Despite US$19 Million Net Loss

Why CrowdStrike (CRWD) Shares Are Getting Obliterated Today

Abercrombie & Fitch Stock Plunges as Outlook Underwhelms

CrowdStrike Collapses 9%--Is This the Beginning of the End or a Massive Buying Opportunity?

Why CrowdStrike Stock Is Plummeting Today

Abercrombie & Fitch (NYSE:ANF) Reports Strong Q4 With Sales Up To US$1.6B And Net Income Rising To US$187M

CrowdStrike Stock Is Down After a Disappointing Forecast, But Analysts Are Still Bullish

Performance Overview